Row
R
RAPPAI Stock Diagnostic Report
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
News that Rapport Therapeutics CEO Abraham Ceesay sold $143,272 worth of company stock is a mild negative.
View Source Article ↗
AI CATALYST SCORE35 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
RAPP Analysis History (Last 30 Days)